ARTICLE | Company News

Merz to acquire BioForm

January 5, 2010 1:27 AM UTC

Merz GmbH & Co. KGaA (Frankfurt, Germany) will acquire dermatology company BioForm Medical Inc. (NASDAQ:BFRM) for $5.45 per share, or about $253 million. The price is a 61% premium to BioForm's close of $3.40 on Dec. 31, the last trading day before the deal was announced. Merz will gain BioForm's Radiesse dermal filler, which is marketed to treat folds and wrinkles and to treat facial lipoatrophy in patients with HIV. Merz said the deal will expand its aesthetic medicine portfolio, which includes dermal fillers Belotero and Novabel. ...